| Pathway ID | hsa04072 |
| Pathway Term | Phospholipase D signaling pathway |
| Pathway Source | KEGG |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
10000 |
Q9Y243 |
chr1: 243,488,233-243,851,079 |
|
ADCY3 |
adenylate cyclase 3 |
109 |
O60266 |
chr2: 24,819,169-24,919,839 |
|
RAPGEF4 |
Rap guanine nucleotide exchange factor 4 |
11069 |
Q8WZA2 |
chr2: 172,735,274-173,052,893 |
|
ADCY7 |
adenylate cyclase 7 |
113 |
P51828 |
chr16: 50,246,137-50,318,135 |
|
ADCY9 |
adenylate cyclase 9 |
115 |
O60503 |
chr16: 3,953,387-4,116,185 |
|
DGKK |
diacylglycerol kinase, kappa |
139189 |
Q5KSL6 |
chrX: 50,365,409-50,470,738 |
|
DGKH |
diacylglycerol kinase, eta |
160851 |
Q86XP1 |
chr13: 42,040,036-42,256,578 |
|
AGTR1 |
angiotensin II receptor, type 1 |
185 |
P30556 |
chr3: 148,697,784-148,743,008 |
|
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
207 |
P31749 |
chr14: 104,769,349-104,795,751 |
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2 |
208 |
P31751 |
chr19: 40,230,317-40,285,536 |
|
F2R |
coagulation factor II (thrombin) receptor |
2149 |
P25116 |
chr5: 76,716,043-76,735,781 |
|
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2 |
22800 |
P62070 |
chr11: 14,277,926-14,364,506 |
|
PLCB1 |
phospholipase C beta 1 |
23236 |
Q9NQ66 |
chr20: 8,077,251-8,968,360 |
|
PIP5K1C |
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma |
23396 |
O60331 |
chr19: 3,630,183-3,700,479 |
|
FYN |
FYN proto-oncogene, Src family tyrosine kinase |
2534 |
P06241 |
chr6: 111,660,332-111,873,452 |
|
GAB1 |
GRB2 associated binding protein 1 |
2549 |
Q13480 |
chr4: 143,336,762-143,474,568 |
|
SHC2 |
SHC (Src homology 2 domain containing) transforming protein 2 |
25759 |
P98077 |
chr19: 416,583-460,996 |
|
GNA12 |
guanine nucleotide binding protein (G protein) alpha 12 |
2768 |
Q03113 |
chr7: 2,728,112-2,844,324 |
|
GNAS |
GNAS complex locus |
2778 |
O95467 |
chr20: 58,839,718-58,911,192 |
|
GRB2 |
growth factor receptor bound protein 2 |
2885 |
P62993 |
chr17: 75,318,076-75,405,709 |
|
GRM3 |
glutamate receptor, metabotropic 3 |
2913 |
Q14832 |
chr7: 86,643,914-86,864,884 |
|
GRM6 |
glutamate receptor, metabotropic 6 |
2916 |
O15303 |
chr5: 178,978,327-178,996,206 |
|
GRM8 |
glutamate receptor, metabotropic 8 |
2918 |
O00222 |
chr7: 126,438,598-127,253,294 |
|
CXCL8 |
chemokine (C-X-C motif) ligand 8 |
3576 |
P10145 |
chr4: 73,740,506-73,743,716 |
|
CXCR2 |
chemokine (C-X-C motif) receptor 2 |
3579 |
P25025 |
chr2: 218,125,289-218,137,253 |
|
INS |
insulin |
3630 |
P01308 |
chr11: 2,159,779-2,161,341 |
|
INSR |
insulin receptor |
3643 |
P06213 |
chr19: 7,112,255-7,294,034 |
|
ARF1 |
ADP ribosylation factor 1 |
375 |
P84077 |
chr1: 228,082,660-228,099,212 |
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
3815 |
P10721 |
chr4: 54,657,918-54,740,715 |
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
3845 |
P01116 |
chr12: 25,204,789-25,250,936 |
|
RHOA |
ras homolog family member A |
387 |
P61586 |
chr3: 49,359,145-49,412,998 |
|
KITLG |
KIT ligand |
4254 |
P21583 |
chr12: 88,492,793-88,580,851 |
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
4893 |
P01111 |
chr1: 114,704,469-114,716,894 |
|
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
|
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
|
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
5156 |
P16234 |
chr4: 54,229,097-54,298,247 |
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 |
P42336 |
chr3: 179,148,114-179,240,093 |
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5291 |
P42338 |
chr3: 138,652,699-138,834,938 |
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 |
O00329 |
chr1: 9,651,732-9,729,114 |
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
5294 |
P48736 |
chr7: 106,865,278-106,907,145 |
|
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
5295 |
P27986 |
chr5: 68,215,720-68,301,821 |
|
PLA2G4A |
phospholipase A2 group IVA |
5321 |
P47712 |
chr1: 186,828,953-186,988,981 |
|
PLCG2 |
phospholipase C gamma 2 |
5336 |
P16885 |
chr16: 81,739,097-81,962,693 |
|
PLD1 |
phospholipase D1 |
5337 |
Q13393 |
chr3: 171,600,405-171,810,950 |
|
AVPR2 |
arginine vasopressin receptor 2 |
554 |
P30518 |
chrX: 153,902,531-153,907,166 |
|
PRKCA |
protein kinase C, alpha |
5578 |
P17252 |
chr17: 66,302,636-66,810,743 |
|
MAPK1 |
mitogen-activated protein kinase 1 |
5594 |
P28482 |
chr22: 21,754,500-21,867,680 |
|
MAPK3 |
mitogen-activated protein kinase 3 |
5595 |
P27361 |
chr16: 30,114,105-30,123,506 |
|
PDGFC |
platelet derived growth factor C |
56034 |
Q9NRA1 |
chr4: 156,760,454-156,971,394 |
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
5604 |
Q02750 |
chr15: 66,386,817-66,492,312 |
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
5605 |
P36507 |
chr19: 4,090,321-4,124,129 |
|
AGPAT3 |
1-acylglycerol-3-phosphate O-acyltransferase 3 |
56894 |
Q9NRZ7 |
chr21: 43,865,186-43,986,536 |
|
AGPAT4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
56895 |
Q9NRZ5 |
chr6: 161,129,979-161,274,061 |
|
PTGFR |
prostaglandin F receptor (FP) |
5737 |
P43088 |
chr1: 78,303,884-78,539,749 |
|
PTPN11 |
protein tyrosine phosphatase, non-receptor type 11 |
5781 |
Q06124 |
chr12: 112,418,351-112,509,913 |
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
5894 |
P04049 |
chr3: 12,583,601-12,664,226 |
|
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
5898 |
P11233 |
chr7: 39,623,483-39,708,124 |
|
RALB |
v-ral simian leukemia viral oncogene homolog B |
5899 |
P11234 |
chr2: 120,240,064-120,294,713 |
|
RALGDS |
ral guanine nucleotide dissociation stimulator |
5900 |
Q12967 |
chr9: 133,097,720-133,149,334 |
|
RHEB |
Ras homolog enriched in brain |
6009 |
Q15382 |
chr7: 151,466,012-151,520,120 |
|
RRAS |
related RAS viral (r-ras) oncogene homolog |
6237 |
P10301 |
chr19: 49,635,292-49,640,201 |
|
SOS1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
6654 |
Q07889 |
chr2: 38,981,396-39,124,345 |
|
SOS2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
6655 |
Q07890 |
chr14: 50,117,120-50,231,558 |
|
SYK |
spleen tyrosine kinase |
6850 |
P43405 |
chr9: 90,801,787-90,898,549 |
|
TSC2 |
tuberous sclerosis 2 |
7249 |
P49815 |
chr16: 2,047,465-2,088,720 |
|
PDGFD |
platelet derived growth factor D |
80310 |
Q9GZP0 |
chr11: 103,907,186-104,164,379 |
|
PIP5K1B |
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
8395 |
O14986 |
chr9: 68,705,414-69,009,176 |
|
DGKZ |
diacylglycerol kinase, zeta |
8525 |
Q13574 |
chr11: 46,332,905-46,380,554 |
|
PLA2G4C |
phospholipase A2 group IVC |
8605 |
Q9UP65 |
chr19: 48,047,843-48,110,817 |
|
PLPP1 |
phospholipid phosphatase 1 |
8611 |
O14494 |
chr5: 55,424,854-55,535,050 |
|
PLPP3 |
phospholipid phosphatase 3 |
8613 |
O14495 |
chr1: 56,494,747-56,645,301 |
|
SPHK1 |
sphingosine kinase 1 |
8877 |
Q9NYA1 |
chr17: 76,376,584-76,387,860 |
|
CYTH3 |
cytohesin 3 |
9265 |
O43739 |
chr7: 6,161,776-6,272,644 |
|
CYTH2 |
cytohesin 2 |
9266 |
Q99418 |
chr19: 48,469,032-48,482,314 |